The JointJYNT -7.49%64 Current Ratio is 1.64 as of Mar. 2026, which is 31% above its 10-year median of 1.25. GuruFocus rates JYNT with a GF Score™ of 64/100 and a GF Value™ of $11.11 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 683 Healthcare Providers & Services companies, The Joint ranks better than 56.66% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. The Joint's current ratio for the quarter that ended in Mar. 2026 was 1.64.
The Joint has a current ratio of 1.64. It generally indicates good short-term financial strength.
The historical rank and industry rank for The Joint's Current Ratio or its related term are showing as below:
JYNT'
s Current Ratio Range Over the Past 10 Years
Min: 0.76 Med: 1.25 Max: 1.83
Current: 1.64
During the past 13 years, The Joint's highest Current Ratio was 1.83. The lowest was 0.76. And the median was 1.25.
JYNT's Current Ratio is ranked better than 56.66% of 683
companies
in the Healthcare Providers & Services industry
Industry Median: 1.47
vs JYNT: 1.64
The Joint (NAS:JYNT) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
The Joint Current Ratio Related Terms
The Joint Current Ratio Historical Data
* Premium members only.
The historical data trend for The Joint's Current Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, The Joint's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
The Joint Current Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, The Joint's Current Ratio distribution charts can be found below:
* The bar in red indicates where The Joint's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The Joint (JYNT) has a Current Ratio of 1.64 as of Mar. 2026. This is 31% above median its historical median of 1.25. Over the past decade, The Joint's Current Ratio has ranged from 0.76 to 1.83. According to the industry distribution chart, The Joint ranks #296 out of 683 companies in the Healthcare Providers & Services industry, placing it in the top 43.3%.
Is The Joint's Current Ratio too high?
The Joint's current Current Ratio of 1.64 is 31% above median its 10-year median of 1.25. Over the past 10 years, this metric has ranged from a low of 0.76 to a high of 1.83. The Healthcare Providers & Services industry median Current Ratio is 1.47. The Joint's value of 1.64 is 11.6% above this industry median. Based on the distribution chart, The Joint ranks #296 out of 683 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, The Joint has a GF Score™ of 64/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does The Joint's Current Ratio compare to MAHN and WW?
According to the Healthcare Providers & Services industry distribution chart, The Joint ranks #296 out of 683 companies for Current Ratio. This puts The Joint in the upper half of its industry. The industry median Current Ratio is 1.47. The Joint's value of 1.64 is 11.6% above this benchmark. Historically, The Joint's own Current Ratio has ranged from 0.76 to 1.83 over the past decade. While the company's 10-year median is 1.25 vs. the industry median of 1.47, The Joint has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Healthcare Providers & Services company?
The median Current Ratio among Healthcare Providers & Services companies is 1.47, based on 683 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. The Joint's current Current Ratio of 1.64 is 11.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median Current Ratio is 1.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. The Joint's current Current Ratio is 1.64, which is 31% above median its own 10-year median of 1.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Joint stock overvalued right now?
Based on GuruFocus' analysis, The Joint (JYNT) is currently considered Modestly Undervalued. The stock's GF Value™ is $11.11, compared to a current price of $8.52 — trading 23.3% below its estimated fair value. The current Current Ratio is 1.64, which is 31% above median its 10-year median of 1.25 and 11.6% above the Healthcare Providers & Services industry median of 1.47. The Joint's overall GF Score™ is 64/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For The Joint (JYNT), the current Current Ratio is 1.64 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is The Joint (JYNT) Overvalued in 2026?
Based on GuruFocus' analysis, The Joint stock appears to be undervalued.
The current stock price of $8.52 is trading 23.3% below its estimated GF Value™ of $11.11.
GuruFocus considers The Joint to be Modestly Undervalued.
Key valuation signals for JYNT:
Current Ratio: 1.64 (31% above median its 10-year median of 1.25)
GF Value™: $11.11 vs. price of $8.52 (23.3% below fair value)
Industry Position: 11.6% above the Healthcare Providers & Services median (#296 of 683)
No single metric tells the full story. See the JYNT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
The Joint Corp develops, owns, operates, supports, and manages chiropractic clinics through direct ownership, management arrangements, franchising, and the sales of regional developer rights throughout the United States. The doctors of chiropractic develop personalized treatment plans to relieve patients' pain and deliver ongoing preventative care. The company has one operating business segment; The Franchise Operations segment, which is comprised of the operating activities of the franchise business unit. The Franchise Operations segment derives revenue from customers by providing access to the company's franchise license, which represents symbolic intellectual property.
64GF Score
Get the complete analysis for JYNT
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
JYNT has been successfully added to your 
